MCM
LLY icon

Mengis Capital Management’s Eli Lilly LLY Stock Holding History

Mengis Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.09M Buy
9,878
+4
+0% +$4.05K 1.56% 17
2025
Q4 		$10.6M Buy
9,874
+500
+5% +$478K 1.88% 11
2025
Q3 		$7.15M Buy
9,374
+480
+5% +$357K 1.41% 15
2025
Q2 		$6.93M Buy
8,894
+1,560
+21% +$1.21M 1.47% 17
2025
Q1 		$6.06M Sell
7,334
-199
-3% -$166K 1.26% 19
2024
Q4 		$5.82M Sell
7,533
-26
-0.3% -$21.5K 1.19% 19
2024
Q3 		$6.7M Buy
7,559
+160
+2% +$144K 1.32% 18
2024
Q2 		$6.7M Sell
7,399
-75
-1% -$60K 1.36% 18
2024
Q1 		$5.81M Buy
7,474
+145
+2% +$103K 0.9% 25
2023
Q4 		$4.27M Sell
7,329
-20
-0.3% -$11.7K 0.8% 31
2023
Q3 		$3.95M Buy
7,349
+124
+2% +$63.9K 0.82% 29
2023
Q2 		$3.39M Buy
7,225
+5
+0.1% +$2.1K 0.68% 41
2023
Q1 		$2.48M Buy
7,220
+57
+0.8% +$19.2K 0.52% 56
2022
Q4 		$2.62M Buy
7,163
+5
+0.1% +$1.77K 0.57% 53
2022
Q3 		$2.31M Buy
7,158
+6
+0.1% +$1.9K 0.55% 53
2022
Q2 		$2.32M Buy
7,152
+6
+0.1% +$1.8K 0.51% 58
2022
Q1 		$2.05M Buy
7,146
+2,207
+45% +$568K 0.39% 64
2021
Q4 		$1.36M Buy
4,939
+6
+0.1% +$1.52K 0.26% 83
2021
Q3 		$1.14M Buy
4,933
+7
+0.1% +$1.73K 0.24% 86
2021
Q2 		$1.13M Buy
4,926
+1,107
+29% +$222K 0.23% 88
2021
Q1 		$713K Buy
3,819
+1,008
+36% +$197K 0.16% 108
2020
Q4 		$474K Buy
2,811
+8
+0.3% +$1.19K 0.12% 120
2020
Q3 		$414K Buy
2,803
+17
+0.6% +$2.63K 0.11% 116
2020
Q2 		$457K Buy
2,786
+9
+0.3% +$1.38K 0.14% 113
2020
Q1 		$385K Buy
+2,777
New +$382K 0.13% 113

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Mengis Capital Management's LLY Position: Q1 2026 in Review

Mengis Capital Management increased its Eli Lilly (LLY) stake by 0.04% in Q1 2026, buying an estimated $4.05K and bringing the position to 9,878 shares worth $9.09M. The position accounts for 1.56% of the portfolio, ranked #17.

Mengis Capital Management first reported a position in LLY in Q1 2020 and has held it in 25 quarters since. The position peaked at $10.6M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mengis Capital Management held 9,878 shares of Eli Lilly worth $9.09M as of Q1 2026.
  • Mengis Capital Management bought 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
  • Eli Lilly made up 1.56% of Mengis Capital Management's portfolio in Q1 2026, its #17 holding.
  • Mengis Capital Management first reported a position in Eli Lilly in Q1 2020 and has held it in 25 quarters since.
  • Mengis Capital Management's Eli Lilly position peaked at $10.6M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mengis Capital Management's 13F filing for Q1 2026, filed 12 May 2026.